A complete report detailing the performance of the building after retrofit against the analyzed pathogens and allergens will be provided. The summary report should be considered sensitive information and public distribution is discouraged, but material becomes proprietary and may be used as deemed appropriate. No information on building capabilities or simulation results will be released outside of IBS, Inc. or published in any form.

Summary reports are open to review and revision based on client feedback or additional concerns that may arise during the design process. Every effort will be made to satisfy client’s individual needs and concerns and to provide practical, cost-effective solutions for the protection of buildings and building occupants against bioterrorism.